Crinetics Pharmaceuticals, Inc. Additional Paid in Capital, Common Stock
Crinetics Pharmaceuticals, Inc. (CRNX) had Additional Paid in Capital, Common Stock of $203.52 million as of 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2019-03-13
- 2018-12-31: Additional Paid in Capital, Common Stock $203.52M.
- 2018-09-30: Additional Paid in Capital, Common Stock $202.38M.
- 2018-06-30: Additional Paid in Capital, Common Stock $2.12M.
- 2017-12-31: Additional Paid in Capital, Common Stock $1.24M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2018-12-31 | $203.52M 10-K · filed 2019-03-13 |
| 2018-09-30 | $202.38M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.12M 10-Q · filed 2018-08-30 |
| 2017-12-31 | $1.24M 10-K · filed 2019-03-13 |